undamentalytics Newsletter
Sign in

Claritev Corp (CTEV) stock

Add to watchlist

Add holding +

NYSE: CTEV NYSE Data Processing & Outsourced Services Next results ~November 9, 2026

D Fundamentals grade

Claritev Corp is a US-listed company in the data processing & outsourced services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Not valued: the figures our models need are missing or failed our data-quality checks.

Price vs value

No model value. How we value companies.

Claritev Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders8 buying, 4 selling18 purchases and 11 sales by directors and officers, last 12 monthsInsider trades
  • Funds66 adding, 34 cuttingOf 18 active managers that changed their stake, 8 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Claritev files

Where Claritev stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $995m, up 6.3% on a year earlier, faster than the 5.5% growth a quarter earlier. Free-cash-flow margin rose to -1.8% from -5.9% a year earlier. Operating margin widened to 3.3% from -37.8%. The diluted share count is up 2.5% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 0 of our 5 financial-health checks.

Our models give no value for Claritev at present, so past values are not shown.

Source: 10-Q filed August 7, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 9, 2026 (estimated)

Claritev Corp's trailing-twelve-month revenue grew 6.3% year on year, with a free-cash-flow margin of -1.8%. Where it stands out: change in growth rate of +0.8pp ranks 2 of 11 data processing & outsourced services companies we cover. Where it lags: long-term debt as % of assets of 97.3% ranks 7 of 7 data processing & outsourced services companies we cover.

Our discounted-cash-flow model values the business at ~$13 per share in the base case (—–$110 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Results well short of expectations: Reported earnings per share missed the analysts' consensus estimate by 321% in the quarter to 2026-06-30.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 41.0 points on a year ago.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 7.2% over 90 days.

Things to watch

  • Results due soon. Results are expected around 6 November; the share price can move sharply on the day.
  • Priced above our value. The share price of $22.92 is 45% above our value per share of $13.
  • Burning cash. Free cash flow was -1.8% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 2.5% in a year.
  • High debt. Long-term debt exceeds cash by $4.6bn, more than 1.5 times annual revenue.
  • Volatile shares. Over the past year the shares showed annualised volatility of 118% and a beta of 2.3 against the S&P 500.

Latest results: FY2026 Q2

Filed August 7, 2026
Earnings per share
-$2.94 against an average estimate of $1.33: missed by 320.9%
Revenue
$257m, up 6.6% on a year earlier
Share reaction
+26.9% in the first session after the results on August 7, 2026, against +0.6% for the S&P 500
Guidance given
revenues $1bn to $1.02bn (full-year 2026); adjusted EBITDA $610m to $620m (full-year 2026)
Next report
November 9, 2026; average EPS estimate $1.71

Claritev's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-4.5%
  • 1 week+6.4%
  • 1 month-3.4%
  • This year-46.4%
  • 1 year-64.8%
  • 5 years-88.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$995M
Operating margin
3.3%
Net margin
-28.5%
EPS (TTM, diluted)
$-16.99

Growth

Revenue growth
+6.3%
Change in growth rate
+0.8 pts
Share count change
+2.5%

Cash

Free cash flow (TTM)
-$17.9M
FCF margin
-1.8%
Stock pay % of revenue
2.9%

Earnings

Last results
August 7, 2026
Next results (est.)
November 6, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Insider trade
  2. Leadership
  3. Leadership
  4. Results
  5. Guidance
  6. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Claritev Corp valuation models and calculator

What the price is pricing in

The share price implies about 4.4% a year of cash-flow growth for five years.That is faster than the -2.3% a year revenue growth Claritev has delivered.

Read with care: free cash flow has swung sharply in the past year (often a one-off tax, legal or working-capital item), so the cash-flow base behind this reading may be unusually low or high.

  • Priced in4.4%
  • Last 12 months6.3%
  • 3 years a year1.0%
  • 5 years a year-2.3%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($22.61, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$13
Price used
$22.61close November 3, 2026
Implied change
▼ 45%
Uncertainty
Very high

How we got here: a discounted-cash-flow model of Claritev Corp's free cash flow after stock-based pay with after-tax interest added back ($264M, FY2026 Q2 TTM), growing 4% and 3.8% in the next two years (forecasts, guidance and its record), then back to 3.6% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span no equity value–~$110 ; that spread sets a 45% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Claritev Corp's free cash flow after stock-based pay ( $264M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Claritev Corp as an operating company, with every model that fits that kind of business. Cost of equity 10.3%: the 10-year Treasury yield (4.9%) plus a beta of 1.18 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$13 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: book value or earnings not available
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$13 ~$13–$110 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Claritev Corp with Data Processing & Outsourced Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% —$32$138$278$461$698
8.5% ——$34$134$264$432
10% ———$48$147$274

Valuation multiples over time Market data may be delayed

At fiscal year end 202020212022202320242025Now
Share price$319.60$177.20$46.00$57.60$14.78$42.75$22.92
Market value$3.8bn$2.9bn$735m$929m$239m$703m$382m
+ Net debt (− = net cash)$4.5bn$4.8bn$4.5bn$4.5bn$4.5bn$4.6bn$4.6bn
Enterprise value$8.2bn$7.7bn$5.2bn$5.5bn$4.8bn$5.3bn$5.0bn
Multiples
Price / sales 4.0x2.6x0.7x1.0x0.3x0.7x0.4x
Price / earnings —28.3x—————
Price / free cash flow 12.3x9.0x2.6x14.8x———
EV / EBITDA —17.0x—22.8x—40.6x37.3x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

20 /100

Weak moat

How hard Claritev's competitive advantage looks for rivals to wear away, judged from 7 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -5.9% of total assets over 7 years.

  • Durability 10 / 20

    Operating margin has been a median -6.7%; its worst year was -97.4%.

  • Cash conversion 11 / 20

    Free cash flow was positive in 4 of 6 years, at a median 8.6% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (35 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 9, 2026, before the open. Analysts expect revenue of $256m and EPS of $1.71 (range $1.71 to $1.71) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $5.81 +146% $1.0bn +5%
Next $7.33 +26% $1.1bn +5%

Next year's EPS estimate has moved +7.2% in 90 days, across 1 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +5.8% on 90 days ago. In the last 30 days, 1 analyst raised Claritev Corp's forecast and 0 cut it.

Consensus EPS forecast Claritev Corp, last 90 days
$5.00 $5.50 $6.00 $6.50 $7.00 $7.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $5.49 Current fiscal year, 60 days ago: $5.58 Current fiscal year, 30 days ago: $5.58 Current fiscal year, 7 days ago: $5.58 Current fiscal year, Now: $5.81 $5.81 Next fiscal year, 90 days ago: $6.84 Next fiscal year, 60 days ago: $6.84 Next fiscal year, 30 days ago: $6.84 Next fiscal year, 7 days ago: $6.84 Next fiscal year, Now: $7.33 $7.33

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $5.49$6.84
60 days ago $5.58$6.84
30 days ago $5.58$6.84
7 days ago $5.58$6.84
Now $5.81$7.33

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $1.33 −$2.94 −320.9%
Mar 2026 $1.38 −$3.30 −338.9%
Dec 2025 $0.85 −$3.19 −475.2%
Sept 2025 −$3.55 −$4.23 −19.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 7, 2026
  • Revenues full-year 2026 $1bn to $1.02bn Raised
    “Revenues $985 million to $1 billion $1 billion to $1.02 billion” source
  • Adjusted EBITDA full-year 2026 $610m to $620m Non-GAAP Raised
    “Adjusted EBITDA 1 $605 million to $615 million $610 million to $620 million” source
  • Capital expenditures full-year 2026 $160m to $170m Maintained
    “Capital expenditures $160 million to $170 million $160 million to $170 million” source
  • Effective tax rate full-year 2026 24% to 28% Maintained
    “Effective tax rate 24% to 28% 24% to 28%” source
  • Free Cash Flow full-year 2026 $5m to $15m Non-GAAP Raised
    “Free Cash Flow $0 million to $10 million $5 million to $15 million” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Claritev Corp's revenue by +4.0% next year and +3.8% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+4.4%, weight 25%) , management guidance (+4.0%, weight 45%) and the company's own record (+3.6%, weight 30%) . How the weights are set.

Analyst recommendations

5 analysts, Oct 2026
Buy480%
Hold120%
Sell00%

Monthly trend

  1. Oct 20262215
  2. Sep 20262316
  3. Aug 20262316

Counts of recommendations published by analysts covering Claritev Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
9.0%
of tradable shares
Days to cover
5.02
at average volume
Short interest, 1 month
−3%
to October 15, 2026
Held by institutions
83%
of shares
Held by insiders
7.3%
of shares
Employees
3,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −64.8%

$65.10 on October 31, 2025 to $22.92

ThenNowEffect
Revenue (last 12 months) $936m $995m +6.3%
P/S multiple 1.1x 0.4x −66.1%
Share count 16m 17m −2.4%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −65.3%

$66.00 on November 3, 2023 to $22.92

ThenNowEffect
Revenue (last 12 months) $966m $995m +3.0%
P/S multiple 1.1x 0.4x −64.9%
Share count 16m 17m −4.0%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CTEV−45%−74%+25%−74%+189%−46%
Industry peers (median)+10%−25%−4%−8%−29%−22%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CTEV33%33%58%33%58%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CTEV−63%−81%−50%−91%−55%−69%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since April 3, 2020: 99% from July 17, 2020 to November 19, 2024. Getting back needed a 9090% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$13.47 – $69.25
From 52-week high
−66.9%
vs 50-day average
−20.3%
vs 200-day average
−10.6%
Volatility (1 year)
119%
Beta vs S&P 500
2.34

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±15.5%
After a week
3 up, 9 down
typical move ±27.7%
After a month
4 up, 8 down
typical move ±37.9%
Results releasedNext dayS&P 500 next day5 days21 days
August 7, 2026 +26.9% +0.6% +42.0% +40.5%
May 7, 2026 +2.0% +0.5% −11.3% +2.3%
February 23, 2026 −41.7% −0.3% −38.0% −34.0%
November 7, 2025 −6.6% +1.7% −30.2% −45.1%
August 6, 2025 +39.0% +0.7% +78.1% +76.7%
May 8, 2025 +2.1% +0.6% +28.8% +81.5%
February 25, 2025 −19.5% −0.4% −34.1% −24.8%
November 5, 2024 −6.5% +3.7% −0.9% −22.6%
August 1, 2024 −23.8% −3.3% −38.0% −47.8%
May 8, 2024 +10.9% +0.6% −3.2% −36.6%
February 29, 2024 −0.9% +1.3% −19.6% −28.3%
November 7, 2023 −6.5% +0.4% −8.4% −14.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Claritev Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: rated Sell.

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: no liquid put and call pair for the same expiry.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Claritev Corp in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Claritev Corp
$920M $940M $960M $980M $1B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $958.5M Revenue (TTM), FY23 Q4: $961.5M Revenue (TTM), FY24 Q1: $959.4M Revenue (TTM), FY24 Q2: $954.9M Revenue (TTM), FY24 Q3: $942.6M Revenue (TTM), FY24 Q4: $930.6M Revenue (TTM), FY25 Q1: $927.4M Revenue (TTM), FY25 Q2: $935.5M Revenue (TTM), FY25 Q3: $951M Revenue (TTM), FY25 Q4: $965.4M Revenue (TTM), FY26 Q1: $978.8M Revenue (TTM), FY26 Q2: $994.7M $994.7M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $958.5M
FY23 Q4 $961.5M
FY24 Q1 $959.4M
FY24 Q2 $954.9M
FY24 Q3 $942.6M
FY24 Q4 $930.6M
FY25 Q1 $927.4M
FY25 Q2 $935.5M
FY25 Q3 $951M
FY25 Q4 $965.4M
FY26 Q1 $978.8M
FY26 Q2 $994.7M
Revenue growth, TTM YoY Claritev Corp
-20% -10% 0% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -15.7% Revenue growth, TTM YoY, FY23 Q4: -10.9% Revenue growth, TTM YoY, FY24 Q1: -5.8% Revenue growth, TTM YoY, FY24 Q2: -1.2% Revenue growth, TTM YoY, FY24 Q3: -1.7% Revenue growth, TTM YoY, FY24 Q4: -3.2% Revenue growth, TTM YoY, FY25 Q1: -3.3% Revenue growth, TTM YoY, FY25 Q2: -2.0% Revenue growth, TTM YoY, FY25 Q3: 0.9% Revenue growth, TTM YoY, FY25 Q4: 3.7% Revenue growth, TTM YoY, FY26 Q1: 5.5% Revenue growth, TTM YoY, FY26 Q2: 6.3% 6.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -15.7%
FY23 Q4 -10.9%
FY24 Q1 -5.8%
FY24 Q2 -1.2%
FY24 Q3 -1.7%
FY24 Q4 -3.2%
FY25 Q1 -3.3%
FY25 Q2 -2.0%
FY25 Q3 0.9%
FY25 Q4 3.7%
FY26 Q1 5.5%
FY26 Q2 6.3%
Operating margin (TTM) Claritev Corp
-150% -100% -50% 0% 50% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -51.4% Operating margin (TTM), FY23 Q4: 16.8% Operating margin (TTM), FY24 Q1: -38.7% Operating margin (TTM), FY24 Q2: -97.4% Operating margin (TTM), FY24 Q3: -138.7% Operating margin (TTM), FY24 Q4: -149.4% Operating margin (TTM), FY25 Q1: -96.4% Operating margin (TTM), FY25 Q2: -37.8% Operating margin (TTM), FY25 Q3: -0.5% Operating margin (TTM), FY25 Q4: 3.0% Operating margin (TTM), FY26 Q1: 2.6% Operating margin (TTM), FY26 Q2: 3.3% 3.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -51.4%
FY23 Q4 16.8%
FY24 Q1 -38.7%
FY24 Q2 -97.4%
FY24 Q3 -138.7%
FY24 Q4 -149.4%
FY25 Q1 -96.4%
FY25 Q2 -37.8%
FY25 Q3 -0.5%
FY25 Q4 3.0%
FY26 Q1 2.6%
FY26 Q2 3.3%
FCF margin (TTM) Claritev Corp
-15% -10% -5% 0% 5% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 7.2% FCF margin (TTM), FY23 Q4: 6.5% FCF margin (TTM), FY24 Q1: 4.3% FCF margin (TTM), FY24 Q2: 6.1% FCF margin (TTM), FY24 Q3: 5.3% FCF margin (TTM), FY24 Q4: -1.1% FCF margin (TTM), FY25 Q1: -10.6% FCF margin (TTM), FY25 Q2: -5.9% FCF margin (TTM), FY25 Q3: -11.8% FCF margin (TTM), FY25 Q4: -1.3% FCF margin (TTM), FY26 Q1: -3.7% FCF margin (TTM), FY26 Q2: -1.8% -1.8%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 7.2%
FY23 Q4 6.5%
FY24 Q1 4.3%
FY24 Q2 6.1%
FY24 Q3 5.3%
FY24 Q4 -1.1%
FY25 Q1 -10.6%
FY25 Q2 -5.9%
FY25 Q3 -11.8%
FY25 Q4 -1.3%
FY26 Q1 -3.7%
FY26 Q2 -1.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 1,041 983 938 1,118 1,080 962 931 965 995
EBITDA 480 424 −71 451 −294 239 −1,302 130 134
Operating income 428 368 −132 386 −363 162 −1,390 29 32
Net income 36 10 −521 102 −573 −92 −1,646 −284 −283
Diluted EPS $3.60 $0.80 −$44.40 $0.16 −$0.90 −$5.69 −$101.92 −$17.30 −$16.99
Growth (year on year)
Revenue — −5.6% −4.6% +19.2% −3.4% −10.9% −3.2% +3.7% +6.3%
EBITDA — −11.6% −116.8% — −165.2% — −644.0% — —
Operating income — −13.9% −135.8% — −193.9% — −958.1% — —
Net income — −73.2% — — −661.2% — — — —
Diluted EPS — −77.8% — — −662.5% — — — —
Margins
EBITDA margin 46.1% 43.1% −7.6% 40.4% −27.2% 24.9% −139.9% 13.5% 13.5%
Operating margin 41.1% 37.5% −14.1% 34.5% −33.6% 16.8% −149.4% 3.0% 3.3%
Net margin 3.5% 1.0% −55.5% 9.1% −53.1% −9.5% −176.9% −29.4% −28.5%
Free-cash-flow margin 22.0% 22.2% 32.7% 28.6% 26.2% 6.5% −1.1% −1.3% −1.8%
Cash flow
Cash from operations 292 284 377 405 372 172 108 117 133
Capital spending 64 66 71 85 90 109 118 130 151
Free cash flow 229 218 307 320 283 63 −11 −12 −18
Stock-based pay 5 −15 406 18 17 18 27 28 29
Free cash flow after stock pay 224 233 −99 302 266 45 −37 −40 −47
Balance sheet
Cash 5 22 127 185 334 72 17 17 14
Total debt 0 5,397 4,578 4,972 4,822 4,600 4,566 4,612 4,637
Net debt (negative = net cash) −5 5,375 4,452 4,786 4,488 4,528 4,549 4,595 4,622
Diluted shares 10m 10m 12m 16m 16m 16m 16m 16m 17m
Returned to shareholders
Buybacks 0 0 101 100 0 15 10 0 —
Total returned 0 0 101 100 0 15 10 0 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

0 of 5 checks passed · June 30, 2026
What it owns · $4.8bn
Short-term assets $236mLonger-term assets $4.5bn
What it owes, and who funded it · $5.1bn
Short-term liabilities $238mLonger-term liabilities $4.8bnShareholders' equity $-295m
  • Short-term assets cover short-term liabilities $236m of assets due within a year against $238m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $236m short-term assets against $4.8bn of longer-dated liabilities.
  • More cash than debt $14m of cash against $4.7bn of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $133m of operating cash flow against $4.7bn of debt.
  • Operating profit covers interest at least five times over Operating income of $32m against $400m of interest.

From Claritev Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2025 Q4 TTM
Buybacks (TTM)
$0
Returned to shareholders
0%
of free cash flow
Buybacks, last 3 fiscal years
$25.6M
Diluted share count
+2.5%
year over year
Total shareholder yield
0.0%
dividends 0.0% + buybacks 0.0% of market value
Days sales outstanding
48 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in data processing & outsourced services
Last 12 months unless stated CTEV TASK ACVA TTEC ALIT CASS Median
Revenue, last 12 months $995m $1.2bn $801m $2.0bn $2.2bn $199m $1.2bn
Revenue growth, last 12 months 6.3% 11.4% 13.3% −4.8% −3.5% 8.8% 6.3%
Revenue growth, 3-year average 1.0% 9.3% 21.5% −6.3% 5.2% 0.9% 7.2%
Revenue growth, latest quarter 6.6% 5.0% 10.4% −11.3% −3.2% 12.5% 5.0%
Operating margin 3.3% 11.7% −7.1% −6.4% −95.7% — −1.6%
Operating margin, 3-year average −44.0% 10.9% −10.9% −3.3% −47.9% — −3.0%
Net margin −28.5% 8.8% −7.9% −10.2% −90.9% 18.5% −7.9%
Cash from operations / revenue 13.4% 14.1% 4.9% 4.2% 15.8% 24.4% 10.9%
Free-cash-flow margin −1.8% 9.8% 3.6% 2.0% 11.2% 21.1% 8.3%
Free-cash-flow margin, 3-year average −0.5% 9.0% 5.7% 0.1% 9.4% 18.6% 5.7%
Stock pay / revenue 2.9% 1.9% 7.4% 0.6% 0.9% 2.3% 1.3%
Change in share count 2.5% −0.1% 2.5% 1.3% 0.0% −3.4% −0.0%

Median of all 11 companies we cover in data processing & outsourced services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 data processing & outsourced services companies
Measure Company Peer median Rank
Revenue growth Growth 6.3% 6.3% 6 of 11
Change in growth rate Growth +0.8pp -1.3pp 2 of 11
Operating margin Profitability 3.3% 3.3% 5 of 10
Net margin Profitability -28.5% -7.9% 9 of 11
Free-cash-flow margin Cash generation -1.8% 8.3% 10 of 11
Stock pay as % of revenue Cash generation 2.9% 1.9% 8 of 10
Long-term debt as % of assets Balance sheet 97.3% 42.4% 7 of 7
Change in share count Balance sheet 2.5% 0.0% 9 of 10
Days sales outstanding Balance sheet 48 days 71 days 2 of 9

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Claims Intelligence Solutions $640M 66.3% ▲ 0.8%
Network Solutions $207M 21.4% ▲ 11.6%
Payment and Revenue Integrity Solutions $119M 12.3% ▲ 7.5%

From Claritev Corp's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$526M
Institutions reporting
102
Shares held vs prior quarter
▲ 9.0%
Positions opened / closed
23 / 14

Top buyers and sellers, Q2 2026: 66 institutions bought and 34 sold ; the biggest buyer was Arini Capital Management Ltd (+1.5M shares) and the biggest seller Barclays PLC (−230K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
H&F Corporate Investors Viii, Ltd. $133M 3.9M 25.2% 0.0%
Arini Capital Management Ltd $105M 3.1M 19.9% ▲ 100.0%
Ares Management LLC $63.6M 1.9M 12.1% 0.0%
Public Investment Fund $43.7M 1.3M 8.3% 0.0%
Beach Point Capital Management LP $26.3M 771K 5.0% ▼ 3.1%
Blackrock, Inc. $24.7M 723K 4.7% ▲ 23.0%
Cpv Partners, LLC $16.9M 495K 3.2% 0.0%
Vanguard Capital Management LLC $14.4M 423K 2.7% ▼ 1.6%
Prudential Financial Inc $12.1M 354K 2.3% 0.0%
Geode Capital Management, LLC $7.7M 225K 1.5% ▲ 18.6%
Caspian Capital LP $6.2M 181K 1.2% ▼ 49.2%
AQR Capital Management LLC $5.9M 174K 1.1% ▲ 398.7%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Claritev Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $4M 18 trades by 8 insiders, last 12 months Insider sales History → $74.1M 11 trades by 4 insiders · 1% under pre-set plans
Net ▼ $70.1M net selling
Insider Date Trade Shares Price Value
Ares Management Llc 10% owner October 26, 2026 Buy 20,834 $24.07 $501,466
Ares Management Llc 10% owner October 23, 2026 Buy 50,000 $23.53 $1.2M
Misencik Tiffani SVP, Chief Growth Officer October 15, 2026 Sell pre-set plan 5,812 $23.81 $138,390
Garis Douglas Michael EVP&CFO September 21, 2026 Sell pre-set plan 7,877 $30.50 $240,248
Garis Douglas Michael EVP&CFO September 21, 2026 Sell pre-set plan 1,148 $31.19 $35,806
Dalton Travis Pres., CEO & Executive Chair August 28, 2026 Buy 1,950 $38.48 $75,036
Dalton Travis Pres., CEO & Executive Chair August 27, 2026 Buy 4,500 $38.81 $174,645
Misencik Tiffani SVP, Chief Growth Officer August 14, 2026 Sell 8,850 $40.07 $354,620
Mintz William B. SVP, Chief Strategy Officer August 10, 2026 Sell 8,431 $34.24 $288,677
Carol Nutter SVP, Chief People Officer June 9, 2026 Buy 875 $28.41 $24,859
Prince John Michael Director May 19, 2026 Buy 10,000 $16.00 $160,000
Dalton Travis Pres., CEO & Executive Chair May 18, 2026 Buy 9,720 $12.92 $125,582

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 6, 2026 estimated from the company's past filing pattern, not announced

  • August 7, 2026
  • May 7, 2026
  • February 23, 2026
  • November 7, 2025
  • August 6, 2025
  • May 8, 2025

Recent SEC filings

Data status

When each part of this page on Claritev Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Claritev Corp in brief

What does Claritev Corp do?
Claritev Corp is a US-listed company in the data processing & outsourced services industry. Its financial year ends in December.
What is Claritev Corp's stock ticker?
Claritev Corp trades under the ticker CTEV on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Claritev Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Claritev Corp reported revenue of $995M, 6.3% higher than a year earlier, according to its SEC filings.
What is Claritev Corp's free cash flow?
Claritev Corp's free-cash-flow margin is -1.8% of revenue over the trailing twelve months, ranking 10 of the 11 data processing & outsourced services companies we cover.
Who are Claritev Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are H&F Corporate Investors Viii, Ltd., Arini Capital Management Ltd and Ares Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Claritev Corp buying back stock, and does it pay a dividend?
Claritev Corp spent $0 on share repurchases over the trailing twelve months, and its diluted share count still rose 2.5% over the year.
What is Claritev Corp's market cap?
On November 2, 2026, Claritev Corp's market capitalisation was about $382M and net debt of $4.6B. Market figures come from third-party market data and may be delayed.
Who are Claritev Corp's competitors?
In our Data Processing & Outsourced Services peer group, the companies closest to Claritev Corp are Taskus, Inc., ACV Auctions Inc., Ttec Holdings, Inc., Alight, Inc. / Delaware and Cass Information Systems Inc. The side-by-side comparison below sets their revenue, margins and growth against Claritev Corp's.
Are insiders buying or selling Claritev Corp stock?
Over the last 12 months, Claritev Corp's directors and officers reported 18 open-market purchases and 11 sales on Form 4. The insider trading page charts every trade.
When is Claritev Corp's next earnings date?
Around November 9, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Claritev Corp announces its own schedule.